Allurion Technologies (ALURD) Asset Writedowns and Impairment (2023 - 2026)
Allurion Technologies' (ALURD) quarterly Asset Writedowns and Impairment came in at $433000.0 in Q1 2026, up 501.39% YoY from $72000.0 in Q1 2025, and up 175.57% on a QoQ basis from -$573000.0 in Q4 2025.
Allurion Technologies (ALURD) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 4 years of Asset Writedowns and Impairment data on file, last reported at $433000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 501.39% year-over-year to $433000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 23.11% YoY) and the FY2025 annual result came in at $1.2 million, down 14.25% from the prior year.
- Asset Writedowns and Impairment rose to $433000.0 in Q1 2026, from -$573000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.5 million in Q3 2023 to a low of -$3.6 million in Q4 2023.
- A 4-year average of $343538.5 and a median of $366000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2025 — Asset Writedowns and Impairment sank 256.56% — and 2026, when it soared 501.39%.
- Tracing ALURD's Asset Writedowns and Impairment over 4 years: stood at -$3.6 million in 2023, then jumped by 110.3% to $366000.0 in 2024, then slumped by 256.56% to -$573000.0 in 2025, then jumped by 175.57% to $433000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $433000.0 (Q1 2026), -$573000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433,000.00 |
| Mar 31, 2026 | 433,000.00 |
| Dec 31, 2025 | -573,000.00 |
| Dec 31, 2025 | -573,000.00 |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 372,000.00 |
| Jun 30, 2025 | 372,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 209,000.00 |
| Mar 31, 2024 | 209,000.00 |
| Dec 31, 2023 | -3.55 Mn |
| Dec 31, 2023 | -3.55 Mn |